Investing.com -- Shares of Apellis Pharmaceuticals (NASDAQ: APLS) fell 8.9% in premarket trading following news that the FDA accepted a revised supplemental application from competitor Astellas Pharma ...

Employers added 256,000 jobs in December despite uncertainty over President-elect Donald Trump's policies. Unemployment dipped to 4.1% ...

Whitecap is forecasting that crude prices may be volatile, “but on balance robust” in 2025, particularly as a weak Canadian dollar tends to work to the benefit of exporters. The company’s price ...

Find insight on BBVA, Australia’s banks and more in the latest Market Talks covering Financial Services.

Daily roundup of research and analysis from The Globe and Mail’s market strategist Scott Barlow ...

Fintel reports that on January 9, 2025, RBC Capital upgraded their outlook for Bank of Montreal (NYSE:BMO) from Sector ...

In a report released on January 7, Luca Issi from RBC Capital maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...

In a report released on January 7, Josh Wolfson from RBC Capital maintained a Hold rating on Newmont Mining (NEM – Research Report), with a ...

CEO Scott Thomson’s next challenge is to offer investors specifics about its Mexican operations in light of President Claudia ...

His comments come as RBC increasingly positions itself to expand in the US market through its advisory, lending, wealth ...

RBC Capital Markets upgraded Bank of Montreal (NYSE:BMO) and Canadian Imperial Bank of Commerce (NYSE:CM) to Outperform from ...